Object. Management of dural arteriovenous fistulas (DAVFs) has changed during the last decades due to increased knowledge of their pathophysiology and natural history as well as advances in treatment modalities. The authors describe the characteristics and long-term outcome of a large consecutive series of patients with DAVFs.
D
ural arteriovenous fistulas represent 10%-15% of all intracranial AVMs according to the 1969 study by Newton and Cronqvist. 47 A more recent Scottish study estimated the detection rate of DAVFs in adults to be 0.16 per 100,000 individuals per year. 3 In the same study the detection rate of brain AVMs was 1.12 per 100,000 individuals per year.
Dural arteriovenous fistulas are most frequently located in the region of transverse, sigmoid, and cavernous sinuses. 35 Patients with transverse-sigmoid sinus DAVFs most commonly present with intolerable pulsatile tinnitus, whereas those with DAVFs in the region of the cavernous sinus usually have exophthalmos and chemosis.
Other symptoms include progressive dementia, seizures, or neurological deficits often caused by intraparenchymal hemorrhage. 35 Classification of DAVFs is based on their venous drainage known to predict their clinical behavior. 4 The most commonly used are the Borden and Cognard classifications (Table 1) . 6, 12 Borden Type I and Cognard Type I and IIa DAVFs drain directly into venous sinuses, whereas in Borden Type II and III and Cognard Type IIb, IIa+b, III, and IV lesions there is direct or indirect reflux to cortical veins, causing more aggressive presentation, including hemorrhage and neurological deficits. Cognard Type V DAVFs drain into spinal perimedullary veins.
In the region of the cavernous sinus, Barrow classification is used to categorize DAVFs. 5 Barrow Type A Characteristics and long-term outcome of 251 patients with dural arteriovenous fistulas in a defined population fistulas are direct high-flow shunts between the ICA and the cavernous sinus. They are usually caused by trauma or rupture of an intracavernous ICA aneurysm. Barrow Type B, C, and D fistulas are true DAVFs with indirect low-flow from meningeal branches of the ICA or ECA, or from both to the cavernous sinus.
In the past decades, advances in neuroradiology (particularly DSA) have led to a better understanding of these lesions, and as microsurgical, endovascular, and radiosurgical techniques have developed, the treatment strategy of DAVFs has also changed. Because DAVFs are relatively rare, only a few large series have been published, and there are still no reports on how evolution of the DAVF treatment strategies has actually changed the results of treatment.
We reviewed a series of 251 consecutive patients with 261 DAVFs admitted to the neurosurgery departments at Helsinki and Kuopio University Hospitals, between 1944 and 2006. The patients underwent microsurgery, endovascular surgery, SRS, a combination of these modalities, or conservative management. In the present study we report the epidemiology, characteristics, and long-term outcome of DAVFs in a defined population based on a 62-year experience in treating these lesions.
Methods

Patients and DAVFs
The study was approved by Helsinki and Kuopio University Hospitals' institutional review boards.
From the 330 intracranial arteriovenous fistulas diagnosed at 2 of the 5 neurosurgical centers in Finland (population 5.3 million), between January 1944 and December 2006, we identified 251 patients with 261 intracranial true DAVFs (Borden Type I-III 6 and Barrow Type B-D fistulas 5 ). The remaining 69 patients had Barrow Type A high-flow carotid-cavernous fistulas, and these cases were excluded from the present study. To determine the incidence of DAVFs, we identified a subgroup of 44 patients admitted to the neurosurgery department of Helsinki University Hospital between 2001 and 2005.
Clinical Characteristics and Radiological Findings
The patients' files and radiological images were retrospectively reviewed. Clinical variables including age, sex, medical history, presenting symptoms, DAVF location, and Borden or Barrow classification were collected (Table 2 ). In all cases the diagnosis of DAVF had been confirmed on carotid artery angiography by direct needle puncture or, since 1989, by DSA. In cases of ruptured DAVFs, CT had been performed since 1980. Magnetic resonance angiograms obtained before treatment were available in 23 patients since 2005. Radiological data were collected from the images between 1988 and 2010 and from the case reports between 1944 and 1987. Clinical and angiographic features, and results of treatment arranged by modality, and techniques according to the DAVF location were compared.
Evolution and Techniques of Treatment Modalities
Until the early 1980s, conservative treatment was preferred in patients in whom symptoms were tolerable. Patients with severe bruit or exophthalmos and rapid visual deterioration were treated by proximal ligation of the feeding artery extracranially, by craniotomy and resection of the sinus, or by ligation of intracranial feeding arteries. In the beginning of the 1980s, the majority of DAVFs were treated by craniotomy. Since 1989 most patients underwent preoperative embolization and subsequent craniotomy. During the past 10 years, embolization has been increasingly used as the first-line therapy, and craniotomies have been performed only in a few cases in which total occlusion could not be achieved by endovascular therapy. Operative treatment has also been the preferred option in fistulas with an intracranial hemorrhage and in those with a high risk of bleeding (Borden Class II and III). Since 2003, SRS has been used as adjuvant therapy after partial endovascular occlusion of benign (Borden Class I) DAVFs with mild or moderate symptoms. Stereotactic radiosurgery has also been used in high-risk (Borden Class II and III) fistulas that have been refractory to microsurgical and endovascular treatments. 15 or with a suture closing the feeding artery. In 3 cases the ICA was ligated both extracranially and intracranially. Another 3 were treated by the combination of proximal vessel ligation and perioperative open embolization of the ECA with fibrin glue or resorbable gelatin hemostatic sponge (Spongostan).
Microsurgical Occlusion. Craniotomy and resection of the fistula or disconnection of the feeding arteries was performed in 29 patients. In the transverse and sigmoid sinus DAVFs, lateral suboccipital craniotomy and resection of the fistula were performed as previously described. 28, 29, 57 If the sinus was functional and provided a major route of venous drainage, coagulation and disconnection of the feeding arteries was preferred. The sinus was removed in case it was nonfunctional or thrombosed, or if there was retrograde flow to cortical veins. Four cavernous sinus fistulas were operated on via the supraorbital lateral approach by occluding the cavernous sinus with fibrin glue and Oxycel. Endovascular Occlusion. Embolization was used in 78 DAVFs. It was performed transarterially and/or transvenously. Until the early 2000s, NBCA and PVA particles were available. We injected NBCA to occlude feeding arteries and PVA particles to reduce flow from smaller feeders and occlude small fistulas. Later, the aim was to occlude the venous part of the DAVF to achieve more patent occlusion. This is performed transarterially with Onyx or transvenously by occluding the sinus with platinum coils. In 4 transverse and sigmoid sinus DAVFs, covered stents were applied inside the affected sinus. In our series, 6 DAVFs were treated with Onyx embolization, which became the treatment of choice after 2006.
Stereotactic Radiosurgery. Since 2003, 16 patients with 17 fistulas have undergone SRS; in 13 patients it was used as adjuvant therapy after embolization or surgery. We used a single-dose stereotactic LINAC therapy (pin-fixation frame, micromultileaf collimator, and doseplanning system [Brainlab] ). Magnetic resonance images followed by stereotactic contrast-enhanced CT scans and DSA images were obtained for the target delineation. A margin dose of 18 Gy covered the whole nidal area except in one large DAVF. The dose to the skin varied from 7 to 12 Gy.
Combined Treatment. Combined therapy (embolization and surgery and/or SRS) was used in 78 DAVFs. In 60 of these DAVFs, preoperative embolization was followed by microsurgical resection of the fistula. Two cavernous sinus fistulas were occluded by embolization followed by craniotomy and injection of glue into the cavernous sinus. Three constantly recurring DAVFs in the area of transverse and sigmoid sinuses were first treated by proximal ligation and feeding artery embolization, and eventually craniotomy and resection of the fistula were performed. Stereotactic radiosurgery was used as adjuvant therapy after subtotal endovascular occlusion of 12 DAVFs. In one case, microsurgery, endovascular therapy, and SRS were used with the intent to reduce several fistulous connections in the sagittal, transverse, and sigmoid sinuses.
Follow-Up
Follow-up data were retrospectively collected (the period comprised the day of admission until death, last follow-up visit, or December 31, 2010). In the early part of the series, only clinical symptoms were followed up, and follow-up angiography was performed only in a few cases with persisting symptoms. Since the 1980s, followup angiography was performed in all treated patients before discharge. Of the 251 patients, there was sufficient clinical data in 236 patients with 246 fistulas to evaluate whether the fistula had been occluded completely. Of the 15 cases lost to follow-up, 13 were traumatic middle meningeal artery lesions and 2 were conservatively treated other traumatic fistulas. The patients whose fistulas were completely occluded and who did not contact the departments after the discharge for recurrent symptoms were considered to be "cured" in the analysis. Repeat angiography was performed only in cases of recurrent symptoms. Patients who received SRS were followed up with DSA, MR angiography, or both annually up to 3 years. The outcomes were clinically graded at the first (at 3 months) and last follow-up appointments. Outcome was measured using the GOS score. Good outcomes were defined as normal life or moderate disabilities (GOS Score 4-5). Fair outcomes were defined as severe disabilities, with dependence of one's care on others (GOS Score 3). Poor outcomes were defined as persistent vegetative state (GOS Score 2) or death (GOS Score 1).
Statistical Methods
Statistical analyses were performed using a commercially available statistical software package (SPSS for 
Results
Patients and DAVFs
Patients. There were 243 adults and 8 children (< 18 years), composed of 139 females and 112 males with a slight female predominance (55.4%). The adults presented at a median age of 55 years (range 18-82 years), and the median age in the children was 6 years (range 0-17 years) ( Table 2 ). Eight patients (3%), 4 women and 4 men, had multiple fistulas (range 2-4 fistulas).
Locations of DAVFs.
Of the 261 DAVFs, 158 (61%) were located in the area of transverse and sigmoid sinuses and 8 (3%) were located in the confluence of sinuses, 27 (10%) in the cavernous sinus, 20 (7.7%) in the middle fossa, 17 (6.5%) in the convexity, 8 (3.1%) in the frontobasal region, 7 (2.7%) in the tentorium, 6 (2.3%) in the superior sagittal sinus, 5 (1.9%) in the foramen magnum, and 5 (1.9%) in other regions including large fistulas in the skull base and convexity (Table 2) . Left-sided predominance was seen in transverse and sigmoid sinus DAVFs-103 (65%) on the left, 52 (33%) on the right, and 3 (1.9%) bilateral or midline lesions.
Of the 261 DAVFs, 27 (10.3%) were traumatic cortical artery lesions, most commonly in the middle meningeal artery, seen on diagnostic angiograms obtained in head trauma patients during the 1960s and 1970s. In 1 trauma patient, DSA was performed due to heavy epistaxis, and 4 traumatic cortical fistulas were revealed. All except 2 of the 24 patients were men.
Cortical venous drainage was present in 88 fistulas (34%), in 34 (24%) women and in 54 (46%) men. The CVD cases included 23 traumatic cortical artery lesions and 65 (28%) of the 234 other fistulas. Fifteen DAVFs (5.7%) included venous pouches, 14 with CVD and 1 without.
According to the Borden classification, 139 (59%) of the 234 fistulas were Type I, 23 (9.8%) were Type II, and 62 (26%) were Type III. Of the 27 cavernous sinus DAVFs, 9 (33%) were Barrow Type B, 4 (15%) were Type C, and 12 (44%) were Type D. In 12 cases (2 cavernous sinus and 10 other locations), the images were absent and the reports did not contain enough data to establish the Borden and Barrow classifications.
Detection Rate of DAVFs. Before the 1970s very few DAVFs were diagnosed. Nine (82%) of the 11 admitted patients had transverse-sigmoid sinus, confluence sinus, or cavernous sinus DAVFs and suffered from severe bruit or exophthalmos. The number of patients increased during the 1970s and again in the 1990s. The large number of trauma cases increased the detection rate of DAVFs in the 1970s. Of the 38 patients diagnosed in the 1970s, 22 had traumatic cortical artery lesions seen on diagnostic angiography, while in the rest of the patients (16), the angiography was performed due to symptoms caused by DAVF. While the use of CT scanning as a diagnostic method for trauma patients began in 1980, the number of DAVFs decreased until 1989, when DSA was introduced. The detection rates and characteristics of DAVFs during past years are presented in Table 3 .
In the subanalysis of patients admitted to the neurosurgery department in Helsinki between 2001 and 2005, 5-14 (mean 8.8) new patients with DAVF were diagnosed annually. The calculated crude incidence of DAVF in the catchment area (range 1,720,068-1,760,743 between 2001 and 2005) was 0.51 per 100,000 individuals per year. For comparison, 95 patients from the database of 623 brain AVMs from the same population and the same period of time were identified. 34 The incidence of brain AVMs was 1.09 per 100,000 persons per year, which is comparable to their current estimated detection rate.
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Etiology of DAVFs. A history of potential etiological factors was available in 64 (25%) of the 251 patients. In 51 patients, a DAVF developed after head trauma at 0-270 days (median 25 days). The patients in whom DAVFs were found on diagnostic angiography in the 1960s and 1970s had sustained severe head trauma and had been ini-tially unconscious; thereafter, most patients with traumatic DAVFs had sustained mild head trauma without unconsciousness. Only 4 patients had been unconscious for more than 24 hours, and 5 had experienced a short period of consciousness lasting only minutes. Four DAVFs were diagnosed after sinus thrombosis-1 with mastoiditis, 4 developed after surgery, and 3 were obviously congenital.
Symptoms of DAVFs.
Pulsating bruit was the most common symptom. Overall, 164 patients (65%) had a bruit, which was mild in 61 (37%) and severe in 103 (63%) of them. Bruit was present in 136 (83%) of the 163 cases without CVD and in 20 (23%) of the 88 cases with CVD.
Other symptoms were headache in 82 patients (33%), chemosis and exophthalmos in 22 (8.8%), hemiparesis in 20 (8.0%), and seizures in 19 (7.6%). Of 158 patients with transverse-sigmoid sinus DAVFs, 137 (87%), 13 (48%) of 27 with cavernous sinus DAVFs, and 14 (21%) of the rest of the patients had bruit. Chemosis and exophthalmos were present in 20 (74%) of 27 patients with cavernous sinus DAVFs. One patient with a transverse-sigmoid sinus DAVF and another with a DAVF in the region of jugular bulb also had chemosis.
Hemorrhage From DAVFs. At the time of diagnosis 34 patients (14%) presented with a hemorrhage (13 transverse and sigmoid sinus, 2 confluence sinus, 4 middle fossa, 4 convexity, 5 superior sagittal sinus, 2 tentorium, 2 frontobasal, 1 foramen magnum, and 1 other). Men more often had hemorrhages than women: 23 (21%) of 112 versus 11 (7.9%) of 139. Cortical venous drainage or a venous pouch was present in 29 (85%) of the 34 patients, with CVD in 21 (62%), a venous pouch in 2 (5.9%), and both in 6 (18%). Of these 34 fistulas, 7 were Borden Type III, 22 were Type II, and 3 were Type I. In 2 cases there were not enough data to make the classification. Overall, bleeding was associated with 33% of the 89 DAVFs that had CVD and/or a venous pouch. Of the 34 patients who had a bleeding, 4 (12%) were completely symptom free, 16 (47%) had headache, 7 (21%) had severe headache and/or neurological deficit, and 7 (21%) were mildly/superficially unconscious for a short period. Notably, bleeding from the DAVF did not lead to a deeply comatose state in any of the patients.
Long-Term Occlusion Rates
Treatment modalities and their results are presented in Table 4 . Overall, 213 of the 261 DAVFs received treatment and 48 underwent observation alone. The conservatively treated group included 21 traumatic DAVFs; 3 lesions that became spontaneously occluded before treatment; and the remaining fistulas were observed because their symptoms were mild.
The overall occlusion success of the DAVFs treated since 1944 was 59%: 45% with proximal occlusion of the feeding artery; 86% with craniotomy and resection of the fistula or cutting the feeding arteries; 100% with cra- (67) 2 (29) 5 (71) 11 (29) 27 (71) 10 (50) 10 (50) 60 (64) 34 (36) 54 (61) (57) 1 (14) 2 (29) 12 (32) 1 (2.6) 25 (66) 15 (71) 1 (4.8) 5 (23) 73 (76) 10 (10) 13 (14) 61 (64) 11 (12) 2 (67) 1 (33) 2 (29) 5 (71) 6 (16) 1 (2.6) 6 (16) 25 (66) 7 (33) 6 (29) 4 (19) 4 (19) 1 (1.0) 10 (10) 45 (47) 37 (39) niotomy and glue injection into the affected sinus; 51% with embolization; 87% with embolization and craniotomy; 60% with embolization and another operation (glue injection); 75% with SRS; and 50% with embolization and SRS. Two (33%) of the 6 Onyx-embolized DAVFs became completely occluded. The 4 partially occluded ones, in which previous embolizations with PVA, NBCA, and coils had failed, were very complex. The occlusion rates for endovascular and combined treatment improved, respectively, from 47% and 74% in the 1990s to 58% and 81% between 2000 and 2006. The occlusion success rate of microsurgery also increased slightly from 80% to 83%.
Repeated Therapy. Twenty of the 53 surgically treated DAVFs required repeated treatment. All of these patients underwent two procedures: 12 underwent repeated craniotomies; 5, proximal ligations of feeding arteries; and 3, proximal ligations followed by a craniotomy. Total occlusion was achieved in 10 (50%) of 20 cases (8, 1, and 1, respectively).
The mean number of embolizations performed before total occlusion or before proceeding with surgery or SRS was 1.96 (range 1-9). In 62 DAVFs, only main feeders were embolized and patients underwent microsurgical resection of the fistula. Endovascular therapy failed in 16 cases, and it was followed by craniotomy and/or SRS (Fig. 1) . Forty-three (55.1%) of the 78 endovascularly treated fistulas required more than one embolization: 2 procedures in 21 (26.9%), 3 procedures in 8 (10.3%), 4 procedures in 7 (9.0%), and 5 or more procedures in 7 fistulas (9.0%). While the total occlusion rate after a single embolization was 21.5%, total occlusion was achieved in 13 cases (16.7%) with 2 embolizations, in 4 cases (5.1%) with 3 embolizations, in 3 cases (3.8%) with 4 embolizations, and in 4 cases (5.1%) with 5 or more embolizations.
Small Remnants and Recurrent DAVFs. Total occlusion was achieved in 142 (67%) of the 213 treated fistulas. In 71 (33%) of the treated DAVFs, only partial occlusion was achieved, mainly after ligation of the feeding arteries or endovascular treatment. Recurrences in these fistulas with remnants were seen particularly after PVA embolization, and some patients developed numerous new fistulous connections, which were even more difficult to treat.
Incurable DAVFs. Three of the 261 DAVFs could not be occluded by any means. One of them, located in the area of transverse and sigmoid sinuses, repeatedly developed new fistulous connections, and transformed from a Borden Type I to Type II lesion. Another one in the area of transverse and sigmoid sinuses has remained open with CVD in spite of endovascular and operative treatment. It reduced in size after SRS but developed new fistulous connections within 7 years of treatment. A third one has resisted any therapy. The 30-year-old patient who harbors this lesion, suffering from severe headaches, was diagnosed with several fistulous connections in the sagittal, transverse, and sigmoid sinuses. Despite several microsurgical and endovascular procedures and SRS, these fistulous connections have recanalized and symptoms have remained. Spontaneous Occlusion. Notably, 12 (25%) of 48 fistulas that were observed occluded spontaneously: 8 of them traumatic in origin; 3 were in the area of transverse and sigmoid sinuses; and 1 was in the cavernous sinus. The median interval between the initial diagnosis and angiography-documented occlusion was 5.1 weeks (range 0.7-73 weeks).
Complications of Treatment
The complications by the DAVF location and the treatment modalities are presented in Table 5 . Overall, there were complications in 46 procedures (18%) in 251 patients. There were 21 severe complications (8.4%) (large infarction, ICH, epidural hematoma, subdural hematoma, or brain swelling)-10 after craniotomy, 10 after embolization, and 1 after SRS. Other complications were postoperative meningitis despite prophylactic antibiotics, deep venous thrombosis, pneumonia, wound infection, severe sepsis, and pulmonary embolism.
Ten patients died within 30 days after the procedure, but only 5 (2.0%) were procedure-related deaths. Three patients died after embolization: one became deeply comatose during embolization and CT showed SAH; another developed a large frontoparietal infarction and a brainstem ICH, and in the autopsy, glue (NBCA) was seen in the sigmoid sinus; and the third patient developed a massive sinus thrombosis 17 days after embolization and developed a large ICH after receiving heparin. Two patients had sudden severe edema intraoperatively, ultimately leading to death (one after microsurgical occlusion and the other after embolization followed by microsurgical occlusion of the DAVF). Other causes of death were pulmonary embolism, cardiac infarction, and purulent meningitis.
After undergoing feeding artery ligation, 2 patients developed cranial nerve palsies (sixth, eighth, and 11th cranial nerves and the recurrent nerve). Severe bleeding (> 1000 ml) occurred in 16 (14%) of the 116 craniotomies performed in 93 patients (17%). There were complications in 24 (21%) of the 116 procedures, of which 9 (7.8%) were severe. Microsurgical occlusion of the transverse and sigmoid sinus DAVFs carried the highest risk of complications-24% overall (9.3% severe). In the cavernous sinus DAVFs, the most complications were seen after craniotomy and glue injection into the cavernous sinus (29%).
Altogether 16 complications (5.1%)-10 (3.2%) severe-were seen after the 313 endovascular procedures performed in the treatment of the 156 DAVFs. The complications were hemorrhagic or ischemic in 11 patients (7.1%) and in 13 procedures (4.2%).
The only SRS-related complication was an ICH due to puncture of a stereotactic frame pin through a bur hole from a previous craniotomy, necessitating evacuation.
Neurological Outcome
The median clinical follow-up duration was 1.1 years (mean 3.1 years; greatest duration 40.2 years). Followup data at 3 months were available in 157 patients. At 3 months, 141 patients (56%) had a good outcome (GOS Score 4-5), 6 (2.4%) had a fair outcome, and 10 (4.0%) had died. At the end of the follow-up, 218 (87%) had a good outcome, and 12 (4.8%) had a fair outcome. Of the 34 patients presenting with a hemorrhage, 27 (79%) had a good outcome, 3 (8.8%) had a fair outcome, 1 (2.9%) had a poor outcome, and 3 (8.8.%) died.
The patients with transverse and sigmoid sinus DAVFs had the best outcome; recovery was good (GOS Score 4-5) in 92% of those with transverse and sigmoid sinus DAVFs and as high as 82% in those who were conservatively treated. Overall, 87% of the patients with a cavernous sinus DAVF had a good recovery. The overall outcome of patients with middle fossa DAVFs was poor, with a good recovery only seen in 65%. However, the patients with poor outcomes had traumatic DAVFs and 8 of them died due to the trauma. One of the 17 patients with convexity DAVFs and one of the 6 patients with superior sagittal sinus DAVFs were disabled due to initial bleeding of the fistula. There was no treatment-related morbidity. In patients with lesions in other locations, 19 (83%) of 23 had a good outcome. The long-term outcomes stratified by period of hospital admission and the DAVF location/ occlusive technique are presented in Tables 3 and 6 , respectively.
Discussion
To the best of our knowledge, this is the first consecutive large population-based series to report the evolution of the treatment of DAVFs, from the ligation of feeding arteries in the 1940s to the present era of Onyx embolization. Microsurgery was the treatment of choice early in the series, but currently it is used only in selected cases due to its relatively high morbidity and mortality rates. Endovascular therapy and SRS have become more widely used, being effective and safe. 50 Onyx embolization with adjuvant SRS, or microsurgery if necessary, is the firstline treatment. 14, 24, 39, 46 
Incidence of DAVFs
The Department of Neurosurgery at Helsinki University Central Hospital serves a population of nearly 1.8 million in Southern Finland and receives all the patients with vascular pathologies from the entire catchment area. In this population the incidence of DAVFs was 0.51 per 100,000 individuals per year between 2001 and 2005. As the incidence of brain AVMs during the same period was 1.09, DAVFs represented 32% of all detected intracranial AVMs. These numbers are 2 or 3 times higher than those reported in the previous few epidemiological studies of DAVFs. The study by Newton and Cronqvist, 47 in which DAVFs represented 10%-15% of all brain AVMs, is commonly referred to when discussing the frequency of DAVFs. Al-Shahi et al. 3 have reported a detection rate of 0.16 per 100,000 individuals per year in their population-based study. The detection rate of 0.15 per 100,000 persons per year was reported by Brown et al. 8 Interestingly a recent Japanese epidemiological survey showed a higher detection rate, 0.29 per 100,000 individuals per year. 51 Notably, for as yet unknown reasons, the incidence of SAH is higher in Finland and Japan than in other European and American populations, although the prevalence of intracranial aneurysms is similar to those of other countries. 62, 63 DAVFs in the Historical Era Patient Characteristics. Before the 1980s, the majority (69%) of the patients with DAVFs were men, and 32 (71%) of the 49 DAVFs were traumatic in origin. The median age in women was 47 years (range 35-64 years), whereas in men it was 39 years (range 4-69 years). During the early part of the series, angiography was performed only in patients with severe bruit or exophthalmos, as well as in patients with head trauma. Nearly all of the traumatic fistulas were diagnosed in the 1970s when traffic and traffic accidents increased. The patients with traumatic cortical artery lesions presented at a median age of 40 years (range 4-69 years). After the introduction of CT scanning in 1980, the proportion of women in the DAVF population increased (50%), as did the median age (58 years, range 25-78 years). Bleeding caused the initial symptoms in 6 (8.7%) of the 69 patients between 1944 and 1989. The transverse-sigmoid sinus, confluence sinus, and cavernous sinus were nearly equally common locations for DAVF until the 1970s when a majority of these lesions, excluding traumatic cortical artery lesions, were seen in the region of the transverse-sigmoid sinus and confluence sinus.
Treatment Modalities and Results. As ligation of the feeding artery carried a relatively high risk of developing neurological symptoms, it was performed in the early part of the series and only in patients who suffered from severe symptoms (bruit and exophthalmos). However, the total occlusion rate was low. Some of the patients did not tolerate the closure of the feeding artery, and the DAVF was left partly open. On the other hand, the fistulas that were totally occluded had a tendency to create new fistulous connections. The total occlusion rate improved from 53%, when feeding artery ligation was used, to 100%, when microsurgery alone was used, by the end of the 1980s, which is in agreement with the literature.
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Of the 23 patients with a traumatic cortical artery fistula, 13 (57%) had good recovery, whereas in other DAVF patients the outcome was good in 83%. Freckmann et al. 23 have already noted that traumatic middle meningeal artery lesions in head trauma patients were associated with poor outcome. In cases in which the head trauma patients survived, the traumatic fistulas documented on diagnostic angiography were usually cured spontaneously or the fistulous connection was occluded as the hematoma was evacuated.
DAVFs in the Modern Era
Patient Characteristics. As in the larger group of patients from the modern era, nearly two-thirds (63%) of the DAVF patients were women since the 1990s. The median age of women was 57 years (range 0-82 years), where in men it was 56 years (range 2-78 years). Of the 191 DAVFs, 134 (70%) were in the region of transverse-sigmoid sinus and confluence sinus, and 21 (11%) were in the cavernous sinus. Bruit was present in 129 (71%) of the 182 patients. Of the 21 patients with cavernous sinus DAVFs, 16 (76%) presented with chemosis and exophthalmos. In the 1990s, 11% of the DAVFs had initially bled, 18% between 2000 and 2006. Other symptoms leading to imaging and diagnosis of DAVF included dizziness, progressive dementia, and local pain around the mastoid process.
Treatment Modalities and Results. In 51% of the cases the DAVF could be occluded by embolization alone, a rate in agreement with those in the literature. 19, 26, 32 Embolization was successful in DAVFs of the convexity, frontobasal area, and foramen magnum, but in transverse and sigmoid sinus DAVFs the total occlusion rate was only 48%. According to the literature, since the introduction of Onyx, the total occlusion rates of DAVFs have markedly increased. 9, 14, 40, 41, 43, 48, 56 However, according to studies by Guedin et al. 25 and Kim et al., 32 lower concentrations of glue and technical advances have increased the total occlusion rate associated with NBCA embolization and therefore it is still a safe and effective method to treat DAVFs, especially Borden Type III lesions.
Combining endovascular treatment and microsurgery resulted in a total occlusion rate of 87%, somewhat lower than that reported by Kakarla et al. 31 in 53 surgically treated high-risk DAVFs. However, in their 119 surgically treated DAVF patients, the treatment-related mortality and morbidity rates were still relatively high, as in our series. Therefore, microsurgery is indicated only when the fistula causes severe symptoms or has a high risk of hemorrhage and cannot be occluded by endovascular means and SRS. It is also considered the treatment of choice in most tentorial and anterior fossa DAVFs that are known to have aggressive behavior and carry a significant risk for complications when managed endovascularly. 1, 4, 27, 31, 36, 45 Nevertheless, successful endovascular obliteration of these DAVFs has been reported in the literature. 2, 14, 20, 30, 42, 58, 59 In our series, the occlusion rate of SRS with the stereotactic LINAC was comparable with that of the Gamma Knife. 11, 24, 33, 37, 49, 54 Still, Yang et al. 64 reported that a higher occlusion rate (83%) was achieved by combined embolization and SRS in their 40 patients.
Risk of Bleeding
Most DAVFs are considered as relatively benign lesions without any previous predisposing factor. 17, 22, 52, 55 Overall, the reported annual risk of hemorrhage is only 1.8%.
7 However, DAVFs with CVD (Borden Types II and III) behave more aggressively, causing ICH and/or SAH. 6, 35, 44, 52, 53, 55, 60, 61 The Toronto Brain Vascular Malformation Group analyzed a subgroup of 20 DAVFs with CVD in their 118 patients. The DAVFs with CVD had an annual hemorrhage rate of 8.1%, nonhemorrhagic neurological deficit rate of 6.9%, and a combined annual event rate of 15%. During the 87 person-year follow-up period, the annual mortality rate was 10.4%. 60 Lower incidence rates with a shorter follow-up duration were reported by Söderman et al. 55 Singh et al. 53 found that being male was an independent risk factor for hemorrhagic presentation of DAVFs, and male predominance (67.6%) was also seen in our hemorrhagic cases.
Prevention of Bleeding
Borden Type I DAVFs. Although Borden Type I DAVFs have benign behavior, they carry a 2% potential for conversion into a lesion with CVD. In reports by Satomi et al. 52 and Cognard et al., 13 CVD developed after incomplete occlusion of the DAVF in most of the patients but also in 3 patients without treatment. Therefore, close clinical follow-up and radiological evaluation in cases in which symptoms change is needed.
Borden Type II and III DAVFs. Because the natural history of DAVFs with CVD is poor, such fistulas require prompt occlusion to prevent bleeding. 18, 50, 60 In particular, Borden Type II and III DAVFs with hemorrhage should be treated early due to their high risk of rebleeding. 21, 55 The Toronto Brain Vascular Malformation Study Group described selective surgical disconnection of CVD as a treatment for DAVFs with cortical venous reflux to prevent an aggressive course. 16, 18 In all 23 of their patients, surgical disconnection of the CVD was the definitive treatment, and there were no hemorrhages or worsening of neurological deficits during the 4.9-year follow-up. 16 Similar results were achieved by Liu et al. 38 in 23 patients treated by selective disconnection of CVD; they noted no recurrences or further clinical events (new hemorrhages or nonhemorrhagic neurological deficits) during a 3.8-year follow-up. Disruption of CVD can also be achieved by endovascular methods. In our series, 25 (28.7%) of the DAVF patients with CVD initially presented with hemorrhage without any other symptoms and, at that point, were treated with intent to fully occlude the fistula. On the other hand, 20 (23.0%) of these patients suffered from an intolerable bruit and therefore required total occlusion of the fistula. In patients without hemorrhage and intolerable symptoms, selective disconnection of CVD could have been considered. In cases with ruptured DAVFs and CVD, total occlusion of the fistula by embolization or craniotomy was our treatment of choice (Fig. 2) because, in our experience, the patients are willing to accept the risk of the procedure rather than live with a patent fistula and a risk of CVD recanalization and rebleeding that requires a close follow-up.
Current Treatment Strategy
The treatment strategy should be tailored individually to patients considering the anatomical features of the DAVF, the severity of symptoms, and the potential risk of intracranial hemorrhage. Most DAVFs can be at least partially treated by endovascularly, which should be the first-line approach to achieving total occlusion. If total occlusion is not achieved, the patient can undergo SRS. Endovascular treatment can also be used as a complementary treatment if there is residual filling after microsurgery. The long-term patency of Onyx embolization is unknown, as in patients treated with PVA and NBCA embolization recurrences after several years have been detected. Stereotactic radiosurgery is indicated in patients who have benign (Borden Type I) fistulas with moderate symptoms but also in patients with high-risk fistulas (Borden Types II and III) refractory to endovascular treatment and microsurgery. However, the process of obliteration after SRS requires some time and not all fistulas respond to treatment even after several years of follow-up. Therefore, SRS cannot be recommended as the first-line treatment in DAVFs that pose a high risk of hemorrhage. Disconnection of CVD should be performed first. Microsurgical treatment of the DAVF has a fairly high attendant morbidity and mortality rate, and therefore it should be used in only carefully selected patients in whom resistance to other treatment modalities has been shown.
Based on our and others' series, the treatment of benign (Borden Type I) DAVFs is indicated if the patient suffers from intolerable symptoms (bruit and exophthalmos) and is aimed at complete occlusion. In our experience, incomplete obliteration of the DAVF may result in redirection of the flow via new fistulous connections and even more complex anatomy and thereby introduce the risk of further treatments. It may also lead to the development of CVD and the risk of hemorrhage. Cortical venous drainage in Borden Type II and III DAVFs causing a high risk of hemorrhage is a strong indication for treatment. Simple disconnection of CVD has been recommended as the treatment of choice in Borden Type III DAVFs but also in Type II DAVFs. 16, 18, 38 However, we prefer occluding the entire DAVF rather than only disconnecting CVD to attain permanent cure.
Conclusions
In our series the detection rate of DAVFs was 0.51 per 100,000 persons per year. The detection rate increased after the introduction of DSA. Advances in endovascular techniques and SRS led to a higher total occlusion rate of DAVFs. Currently, microsurgery is of limited use in patients with DAVFs with intolerable symptoms and resistance to other treatment modalities.
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